Bryostatin-1: A Novel PKC Inhibitor in Clinical Development

This publication has 79 references indexed in Scilit:

• Modulation of cIAP-1 by Novel Antitubulin Agents When Combined with Bryostatin 1 Results in Increased Apoptosis in the Human Early Pre-B Acute Lymphoblastic Leukemia Cell Line Reh
  Biochemical and Biophysical Research Communications, 1999
• Proteolytic cleavage of protein kinase Cμ upon induction of apoptosis in U937 cells
  FEBS Letters, 1999
• Regulation of Motility and Protease Expression in PKC-Mediated Induction of MCF-7 Breast Cancer Cell Invasiveness
  Experimental Cell Research, 1999
• Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937)
  Differentiation, 1998
• Establishment of a Human Pancreatic Tumor Xenograft Model
  Pancreas, 1998
• The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF‐7 breast carcinoma cells
  International Journal of Cancer, 1994
• Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients
  Surgical Oncology, 1993
• Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastases
  Surgical Oncology, 1992
• Conversion of high grade lymphoma tumor cell line to intermediate grade with tpa and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis
  Hematological Oncology, 1990
• Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin
  Carcinogenesis: Integrative Cancer Research, 1987